The market size for treating global degenerative disc disease was valued at USD 26.05 billion in 2021. It is estimated to increase from USD 27.87 billion in 2022 to USD 45.92 billion by 2029, showing a compound annual growth rate (CAGR) of 7.4% during the forecast period.